Close Menu

DNAnexus

Natera has installed its software on DNAnexus' platform and will use the combined solutions to provide data analysis, storage, and sharing for its genetic tests.

NEW YORK (GenomeWeb) – DNAnexus said this week that its cloud-based data management and analysis platform is being used in partnerships between Regeneron Genetics Center (RGC) and healthcare providers that are focused on integrating next-generation sequence data with de-identified clinical record

People in the News: Tim O'Brien

Premium

DNAnexus has hired Tim O’Brien to be VP of sales. In this role, he will be responsible for building and managing the DNAnexus enterprise sales organization and developing the company’s go-to-market sales strategy.

DNAnexus has hired David Shaywitz to be its chief medical officer.

This week, Bina Technologies released the Bina Annotation Platform, a new cloud-based addition to its genomic analysis product suite.

DNANexus said recently that it has raised $15 million in a Series C financing round, and company officials told BioInform this week that the funds are earmarked for commercialization efforts and to scale up to better support global customers.

NEW YORK (GenomeWeb News) — DNAnexus today said that it has closed a $15 million Series C round of financing.

Appistry has added ContEst, a new tool for estimating cross-contamination in NGS tumor/normal samples, to its Cancer Genome Analysis suite.

This week, DNAnexus and the Human Genome Sequencing Center at Baylor College of Medicine shared details of a cloud-based collaborative analysis project in which they processed whole-genome and whole-exome data from more than 14,000 individuals for a study that aims to understand

NEW YORK (GenomeWeb News) – The Human Genome Sequencing Center at Baylor College of Medicine and DNAnexus today announced a collaboration aimed at the large-scale analysis of genomic data.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.